Dry-Reagent-Based Molecular Assay Facilitates Diagnosis of Buruli Ulcer
By LabMedica International staff writers Posted on 19 Apr 2015 |
Image: The Chromo4 Real-Time Polymerase Chain Reaction Detector (Photo courtesy of Bio-Rad).
Image: Buruli ulcer on a leg of a patient in Ghana (Photo courtesy of Dr. K. Asiedu).
Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans causing a skin disease which is the third most common mycobacterial disease and its rapid diagnosis and treatment are essential.
Polymerase chain reaction (PCR) is considered to be the most sensitive method for the laboratory confirmation of Buruli ulcer, but this technique remains expensive and involves reagents unsuitable for use in tropical countries with poor storage conditions, hindering the development of reliable quantitative PCR (qPCR) diagnosis.
Scientists from various French institutions including the University of Angers (France) compared the efficiency of three different dry qPCR mixes, lyophilized with various concentrations of cryoprotectants, with that of a freshly prepared mixture, for the detection of a standard range of M. ulcerans DNA concentrations. They evaluated the heat resistance of the dry mixes, comparing them with the fresh mix after heating. They also evaluated one of the dry mixes in field conditions, by analyzing 93 specimens from patients with suspected Buruli ulcers.
For validation of the dry mix in field conditions, the selected dry mix was evaluated on 48 swabs, 27 tissue samples, and 18 fine-needle aspirates (FNAs) from 93 patients with suspected Buruli ulcer. DNA amplification and detection were performed with a Chromo4 thermal cycler (Bio-Rad; Hercules, CA, USA). The dry mix was highly resistant to heat, of similar sensitivity and efficiency to the fresh mix and easier to use than the fresh mix. The investigators found 55 specimens were positive for M. ulcerans DNA and 38 were negative.
The authors concluded that dry qPCR mixes are suitable for use in the diagnosis of M. ulcerans infection in endemic countries. The user-friendly format of this mix makes it possible for untrained staff to perform diagnostic tests with a limited risk of contamination. The possibility of using this mix in either vial or strip form provides considerable flexibility for the management of small or large amounts of sample. The dry-mix qPCR could be used as a reliable tool for the diagnosis of Buruli ulcer in the field. The study was published on April 1, 2015, in the journal Public Library of Science Neglected Tropical Diseases.
Related Links:
University of Angers
Bio-Rad
Polymerase chain reaction (PCR) is considered to be the most sensitive method for the laboratory confirmation of Buruli ulcer, but this technique remains expensive and involves reagents unsuitable for use in tropical countries with poor storage conditions, hindering the development of reliable quantitative PCR (qPCR) diagnosis.
Scientists from various French institutions including the University of Angers (France) compared the efficiency of three different dry qPCR mixes, lyophilized with various concentrations of cryoprotectants, with that of a freshly prepared mixture, for the detection of a standard range of M. ulcerans DNA concentrations. They evaluated the heat resistance of the dry mixes, comparing them with the fresh mix after heating. They also evaluated one of the dry mixes in field conditions, by analyzing 93 specimens from patients with suspected Buruli ulcers.
For validation of the dry mix in field conditions, the selected dry mix was evaluated on 48 swabs, 27 tissue samples, and 18 fine-needle aspirates (FNAs) from 93 patients with suspected Buruli ulcer. DNA amplification and detection were performed with a Chromo4 thermal cycler (Bio-Rad; Hercules, CA, USA). The dry mix was highly resistant to heat, of similar sensitivity and efficiency to the fresh mix and easier to use than the fresh mix. The investigators found 55 specimens were positive for M. ulcerans DNA and 38 were negative.
The authors concluded that dry qPCR mixes are suitable for use in the diagnosis of M. ulcerans infection in endemic countries. The user-friendly format of this mix makes it possible for untrained staff to perform diagnostic tests with a limited risk of contamination. The possibility of using this mix in either vial or strip form provides considerable flexibility for the management of small or large amounts of sample. The dry-mix qPCR could be used as a reliable tool for the diagnosis of Buruli ulcer in the field. The study was published on April 1, 2015, in the journal Public Library of Science Neglected Tropical Diseases.
Related Links:
University of Angers
Bio-Rad
Latest Molecular Diagnostics News
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans
- Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
- Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
- Low-Cost Point-Of-Care Diagnostic to Expand Access to STI Testing
- 18-Gene Urine Test for Prostate Cancer to Help Avoid Unnecessary Biopsies
- Urine-Based Test Detects Head and Neck Cancer